The unwanted consequences of the most recent protocols of NBS for CF (i.e., inclusion of CFTR variants’ studies) include the identification of carrier status [6] and the emergence of a cohort of infants with positive NBS test results but an inconclusive diagnosis [7,8,9]. This evidence concerns the gene CFTR and cystic fibrosis.